Global Pharmaceutical Lysozyme Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Pharmaceutical Lysozyme market size was valued at US$ 43.8 million in 2024 and is forecast to a readjusted size of USD 59.5 million by 2031 with a CAGR of 4.5% during review period.

Pharmaceutical Lysozyme is an enzyme that is naturally present in various bodily fluids, including tears, saliva, and mucus. It plays a crucial role in the immune system as a defense mechanism against bacterial infections. Lysozyme works by breaking down the bacterial cell walls, leading to the destruction of the bacteria.

Lysozyme, can be manufactured by egg white or microbial fermentation. Presently, feed grade lysozyme is mainly produced via microbial fermentation, while lysozyme made from egg white is widely used in food industry, pharma industry, etc. Enzyme activity is a very key indicator for pharmaceutical lysozyme. The much higher the activity of lysozyme is, the more expensive of its price.

Major production of pharmaceutical plysozyme is distributed in Europe. Bioseutica and Bouwhuis Enthoven are representatives of the industry.

The market for pharmaceutical plysozyme is influenced by several key drivers:

Antimicrobial Properties: Lysozyme's effectiveness against bacteria makes it valuable in pharmaceuticals, particularly in formulations aimed at treating infections or as preservatives in medications.

Rising Incidence of Infectious Diseases: The growing prevalence of bacterial infections boosts the demand for effective antimicrobial agents, including lysozyme.

Pharmaceutical Innovations: The development of new formulations that incorporate lysozyme can expand its applications, particularly in innovative drug delivery methods.

This report is a detailed and comprehensive analysis for global Pharmaceutical Lysozyme market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Pharmaceutical Lysozyme market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031

Global Pharmaceutical Lysozyme market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031

Global Pharmaceutical Lysozyme market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031

Global Pharmaceutical Lysozyme market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Pharmaceutical Lysozyme

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Pharmaceutical Lysozyme market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bioseutica, Bouwhuis Enthoven, EPS S.P.A, Kewpie, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Pharmaceutical Lysozyme market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Lysozyme Solution
Lysozyme Powder

Market segment by Application
Nasal and Throat Preparations
Dental Care
Other

Major players covered
Bioseutica
Bouwhuis Enthoven
EPS S.P.A
Kewpie

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Pharmaceutical Lysozyme product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Pharmaceutical Lysozyme, with price, sales quantity, revenue, and global market share of Pharmaceutical Lysozyme from 2020 to 2025.

Chapter 3, the Pharmaceutical Lysozyme competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pharmaceutical Lysozyme breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pharmaceutical Lysozyme market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Lysozyme.

Chapter 14 and 15, to describe Pharmaceutical Lysozyme sales channel, distributors, customers, research findings and conclusion.